Beta Bionics (BBNX) Capital Expenditures (2024 - 2026)

Beta Bionics has disclosed Capital Expenditures across 3 years of filings, most recently posting $1.4 million for Q1 2026.

• Capital Expenditures for Q1 2026 came in at $1.4 million, up 313.51% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.3 million (up 90.88% YoY), and the FY2025 annual result was $5.3 million, up 56.02% from the prior year.
• Capital Expenditures came in at $1.4 million for Q1 2026 at Beta Bionics, down from $5.3 million in the prior quarter.
• In the past five years, Capital Expenditures ranged from a high of $5.3 million in Q4 2025 to a low of -$232000.0 in Q2 2025.
• The 3-year median for Capital Expenditures is $550000.0 (2024), against an average of $1.1 million.
• Peak annual rise in Capital Expenditures reached 837.43% in 2025, while the deepest fall reached 142.18% in 2025.
• Beta Bionics' Capital Expenditures stood at $561000.0 in 2024, then surged by 837.43% to $5.3 million in 2025, then slumped by 73.82% to $1.4 million in 2026.
• The last three Capital Expenditures figures came in at $1.4 million (Q1 2026), $5.3 million (Q4 2025), and -$63000.0 (Q3 2025), per Business Quant data.